Search
Search Results
##search.searchResults.foundPlural##
-
Sickle cell disease and Bartonella spp. infection
1401PDF: 1449HTML: 498 -
HAS HEMATOPOIETIC STEM CELL TRANSPLANTATION A ROLE IN THE TREATMENT OF CHILDREN AND ADOLESCENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA? Acute Promyelocytic Leukemia and Hematopoietic Stem Cell Transplantation
1392PDF: 917HTML: 272 -
-
PREVALENCE OF ANEMIA, IRON DEFICIENCY, AND IRON DEFICIENCY ANEMIA AND DIAGNOSTIC PERFORMANCE OF HEMATOLOGIC AND BIOCHEMICAL MARKERS OF SIDEROPENIA IN 1- TO 5-YEAR-OLD CHILDREN IN THRACE GREECE Prevalence of ID, IDA and anemia in Greek Thrace
2360PDF: 971HTML: 500 -
RELIABILITY OF DIFFERENT RBC INDICES AND FORMULAS IN DISCRIMINATING BETWEEN ?-THALASSEMIA MINOR AND OTHER CAUSES OF MICROCYTIC HYPOCHROMIC ANEMIA
3163PDF: 1692HTML: 14679Untitled: 263Untitled: 216 -
Aplastic anaemia with microfilaria in marrow aspirate
1655PDF: 853HTML: 1374 -
WHAT ARE FUNGAL INFECTIONS?
4400PDF: 2506HTML: 27707de Pauw: 290 -
Leukocyte derived chemotaxin 2 (ALECT2) amyloidosis
1718PDF: 841HTML: 1341 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3961PDF: 1373HTML: 969Figure 2: 511Figure 1: 3197 -
SEROPOSITIVITY OF HEPATITIS B AND C AMONG SYRIAN MULTITRANSFUSED PATIENTS WITH HEMOGLOBINOPATHY
3554PDF: 810HTML: 1133Cover Letter: 242 -
Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia
1576PDF: 910HTML: 1117Untitled: 221 -
EPIDEMIOLOGY OF THERAPY-RELATED MYELOID NEOPLASMS IN THE NORDIC COUNTRIES
2381PDF: 885HTML: 1705Figure 1: 250Table 1: 255 -
DONOR KIR3DL1/RECEPTOR HLA-BW4-80I COMBINATION REDUCES ACUTE LEUKEMIA RELAPSE AFTER UMBILICAL CORD BLOOD TRANSPLANTATION WITHOUT IN VITRO T-CELL DEPLETION KIR3DL1 with HLA-Bw4-80I reduces leukemia relapse
1530PDF: 626HTML: 247 -
PROPHYLAXIS OF MALARIA
3120PDF: 1104HTML: 18054Figures SChwartz: 208 -
SARS-CoV-2 INFECTED PATIENTS: FROM A HEMATOLOGIST PERSPECTIVE COVID-19 and Hematology
1564PDF: 1021HTML: 451 -
TREATMENT OF LOW-BLAST COUNT AML USING HYPOMETHYLATING AGENTS
4582PDF: 1825HTML: 1128 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
912PDF: 518HTML: 1318 -
CD48 AS A NOVEL EARLY BIOMARKER COMPLEMENTING PROCALCITONIN AND LACTATE FOR PREDICTING BACTEREMIA IN PEDIATRIC FEBRILE NEUTROPENIA: A PROSPECTIVE COHORT STUDY CD48 A NOVEL EARLY BIOMARKER PREDICTING BACTERIEMIA
1083PDF: 812HTML: 134 -
GENETIC PATHWAYS LEADING TO THERAPY-RELATED MYELOID NEOPLASMS
2703PDF: 869HTML: 5388 -
IMMUNE THROMBOCYTOPENIA ONSET AND RELAPSE DURING THE COVID19 PANDEMIC. A MONOCENTER STUDY. ITP and COVID19 infection and vaccination
1637PDF: 962HTML: 389 -
DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES: ANALOGIES AND DIFFERENCES DE NOVO AND THERAPY-RELATED MYELODYSPLASTIC SYNDROMES
1672HTML: 696PDF: 914 -
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA
8390PDF: 4512HTML: 7583 -
EVALUATION OF THE PLASMA MICRO RNA EXPRESSION LEVELS IN SECONDARY HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS
1491PDF: 751HTML: 1191Untitled: 224Untitled: 187Untitled: 178Untitled: 192Untitled: 207







